filmov
tv
HDSA RESEARCH WEBINAR: Novartis Discusses the VIBRANT-HD Trial
Показать описание
On Wednesday, February 22, 2023, clinical leaders and Novartis representatives will talk about the VIBRANT-HD trial and the decision to stop development of branaplam in HD, and answered community questions.
Speakers included VIBRANT-HD clinical site investigator and chair of the trial Steering Committee Dr. Blair Leavitt, Director of Research and Consultant Neurologist at the UBC Centre for Huntington Disease; Medical lead for the branaplam program, Dr. Harry Ramos, Senior Clinical Development Medical Director at Novartis, and Clinical program head for the branaplam program, Dr. Beth Borowsky, Executive Director and Senior Global Program Clinical Head at Novartis.
#LetsTalkAboutHD #HuntingtonsDisease #HDSAFamily
Speakers included VIBRANT-HD clinical site investigator and chair of the trial Steering Committee Dr. Blair Leavitt, Director of Research and Consultant Neurologist at the UBC Centre for Huntington Disease; Medical lead for the branaplam program, Dr. Harry Ramos, Senior Clinical Development Medical Director at Novartis, and Clinical program head for the branaplam program, Dr. Beth Borowsky, Executive Director and Senior Global Program Clinical Head at Novartis.
#LetsTalkAboutHD #HuntingtonsDisease #HDSAFamily
0:56:56
0:53:10
1:00:40
0:52:00
1:00:09
1:08:57
1:08:51
1:01:42
1:09:59
1:09:32
0:37:09
0:57:11
1:42:12
0:50:09
0:51:15
1:04:45
0:57:27
0:17:58
1:06:01
0:47:05
0:06:46
1:00:21
0:15:34
0:01:50